1. United States of America Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Rejuvel Bio-Sciences, Inc.

Rejuvel Bio-Sciences, Inc.

NUUU
Rejuvel Bio-Sciences, Inc.US flagOther OTC
0.00
USD
- -
- -
117,765.00Market Cap
Rejuvel Bio-Sciences, Inc.
NUUU
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
TTM
FRC
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.01
-0.01
-0.01
-0.01
- -
-0.02
Basic EPS, GAAP
-0.01
-0.01
-0.01
- -
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.01
-0.01
-0.01
-0.02
-0.07
Book Value per Share
-0.01
- -
- -
-0.01
-0.01
-0.03
Tangible Book Value per Share
3
25
117
117
95
51
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
-15,189.2
-8,494.36
-1,027.38
-730.32
-672.7
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-1
-1
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-15,189.2
-10,453.43
-1,387.82
-375.01
-561.59
Profit Margin (%)
- -
- -
- -
-1
-1
-2
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
-1
-1
-2
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
10.16
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
51
51
Market Capitalization
73
42
15

Working Capital

FRC

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
2
2
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-24.33%
Free Cash Flow
- -
- -
71.16%
Net Income, GAAP
- -
- -
-50.69%
Sales/Revenue/Turnover
- -
- -
82.5%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
-0.01
2014
-0.02
0.01
- -
- -
- -
2015
- -
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
Similar Companies
The Stephan Co. (SPCO)
Cota Co., Ltd. (4923.T)
Karex Berhad (5247.KL)
Gr. Sarantis S.A. (SRTSF)
JHS Svendgaard Laboratories Limited (JHS.NS)
N.K Industries Limited (NKIND.BO)
Business
Rejuvel Bio-Sciences, Inc. develops, produces, distributes, markets, and sells technologically advanced skin care products worldwide through its subsidiaries, including Rejuvel Int'l, Inc. and Zero Gravity Sciences, Inc.. The company offers its flagship Rejuvel brand skin creams, such as Rejuvel 3D Ageless Infinity Microgravity Cell Renewal Cream, a three-dimensional skin renewal system utilizing plant stem cells grown in NASA-licensed simulated microgravity bioreactors to promote cellular healing, wrinkle reduction, and skin rejuvenation; it also pursues environmental management solutions employing electron particle accelerator technology for treating drinking water, wastewater, sludge, and oil and gas produced water. Founded in 2009 and headquartered at Chase Bank Building, 150 SE 2nd Avenue, Suite 403, Miami, Florida, the company formerly known as Technology Applications International Corporation changed its name in June 2015 and operates primarily in the household and personal products sector, targeting consumer skincare markets with one employee as of recent reports. Recent activities include its subsidiary Zero Gravity Sciences, Inc., a joint venture with Brand Labs USA, LLC, launching new product lines and a website; expanding international distribution through agreements in Trinidad & Tobago and the Caribbean region; and securing initial orders from new partnerships, alongside plans for medical formulations as revenues grow.

Company News

APIChatGPT

  • defenseworld.net

    Head to Head Contrast: Rejuvel Bio-Sciences (OTCMKTS:NUUU) & Helen of Troy (NASDAQ:HELE)

  • defenseworld.net

    Reviewing Solesence (NASDAQ:SLSN) and Rejuvel Bio-Sciences (OTCMKTS:NUUU)